SAMD9 and Bone marrow hypocellularity: Chromosome 7 contains the SAMD9 gene loci, and deletion of the antiproliferative SAMD9 GOF mutant results in a clonal selective advantage referred to as revertant mosaicism which mitigates bone marrow failure but precipitates hematologic malignancy [7, 18].